Download presentation
Presentation is loading. Please wait.
1
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
NMPhA Mid-Winter Meeting – Law Update January 27, 2018
2
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
Peter Ryba, PharmD Maria Gonzales PMP Director PMP Manager
3
Agenda Prescription Drug Information and Statistics What is the PMP?
Prescription Monitoring Program New Mexico Board of Pharmacy Agenda Prescription Drug Information and Statistics What is the PMP? PMP Registration Process PMP Regulatory Facts PMP InterConnect PMP AWARxE Reports Provided Current Projects Useful Links
4
Prescription Drug Information and Statistics
Prescription Monitoring Program New Mexico Board of Pharmacy Prescription Drug Information and Statistics The National Epidemic The United States is in the midst of an epidemic of prescription opioid overdose deaths, which killed more than 63,600 people in 2016 alone. 14,000 people in 2014 alone. Source: NCHS Data Brief, Number 294, December
5
Prescription Drug Information and Statistics
Prescription Monitoring Program New Mexico Board of Pharmacy Prescription Drug Information and Statistics Source:
6
Prescription Monitoring Program
New Mexico Board of Pharmacy Drug poisoning (overdose) deaths: Includes deaths resulting from unintentional or intentional overdose of a drug, being given the wrong drug, taking a drug in error, or taking a drug inadvertently. Natural and semisynthetic opioids: Includes such drugs as morphine, codeine, hydrocodone, and oxycodone. Synthetic opioids other than methadone: Includes such drugs as fentanyl, fentanyl analogs, and tramadol. Source: NCHS Data Brief, Number 294, December 2017
7
Prescription Monitoring Program
New Mexico Board of Pharmacy Source: NCHS Data Brief, Number 294, December 2017
8
Prescription Drug Information and Statistics
Prescription Monitoring Program New Mexico Board of Pharmacy Prescription Drug Information and Statistics The State of New Mexico In 2014, New Mexico had the second highest drug overdose death rate. In 2015, New Mexico ranked #8 with a rate of 25.3. In 2016, New Mexico ranked #12 with a rate of 25.2. Age adjusted, per 100,000 West Virginia (52.0 per 100,000) Ohio (39.1) New Hampshire (39.0) the District of Columbia (38.8) Pennsylvania (37.9) Source:
9
Prescription Drug Information and Statistics
Prescription Monitoring Program New Mexico Board of Pharmacy Prescription Drug Information and Statistics Source: NCHS Data Brief, Number 294, December 2017
10
Prescription Monitoring Program
New Mexico Board of Pharmacy Drug Overdose Death Rates for the 8 States with the Highest Rates in 2015 Source: NM Department of Health
11
Prescription Drug Information and Statistics
Prescription Monitoring Program New Mexico Board of Pharmacy Prescription Drug Information and Statistics Northwest Northeast San Juan 19 Santa Fe 45 Cibola 10 Rio Arriba 31 Central/Metro Bernalillo 187 Sandoval 21 Southwest Southeast Dona Ana 27 Lea 14 Otero 12 Chaves 13 Top two counties re: OD deaths per region using 2016 data Source: NM Department of Health
12
Prescription Drug Information and Statistics
Prescription Monitoring Program New Mexico Board of Pharmacy Prescription Drug Information and Statistics Year Nat’l Rank OD Deaths Rate 2014 2nd th th Source: NM Department of Health
13
Prescription Monitoring Program
New Mexico Board of Pharmacy What is the PMP? The New Mexico Prescription Monitoring Program is a web-based electronic database that aids in the collection and reporting of dispensed controlled substance prescriptions.
14
Prescription Monitoring Program
New Mexico Board of Pharmacy What is the PMP? Mission To provide practitioners, pharmacists, and other authorized users the ability to review a patient’s controlled substance prescription history and assist in the prevention of diversion, abuse, misuse, and drug overdose deaths of controlled substance prescriptions.
15
Prescription Monitoring Program
New Mexico Board of Pharmacy What is the PMP? Information in the PMP is only as accurate as the data submitted by dispensers. Disclaimer: “The State of New Mexico does not warrant the above information to be accurate or complete. This report is based on the search criteria entered and the data entered by the dispenser. For more information about any prescription, please contact the dispenser or the prescriber.”
16
Prescription Monitoring Program
New Mexico Board of Pharmacy What is the PMP? PMP reports should not be used as evidence or testimony for any legal proceedings. The PMP is a tool for prescribers to use their professional judgement in prescribing controlled substances.
17
Prescription Monitoring Program
New Mexico Board of Pharmacy History of the NM PMP July 2004 – NMAC was adopted which created the PMP. August 2005 – The PMP went live and was operated under the NM BOP. October 2014 – The NM BOP was awarded the 2014 Harold Rogers grant. November 2016 – Appriss began hosting the NM PMP. January 2017 – The NM State Legislature enacted new mandatory PMP use requirements for all practitioners. NMAC – New Mexico Administrative Code
18
PMP Registration Process
Prescription Monitoring Program New Mexico Board of Pharmacy PMP Registration Process Registrants include: Healthcare Professionals Delegates Up to four (4) delegates per practitioner A delegate can have an unlimited number of practitioners Law Enforcement Regulatory Board Agents Medicaid Compliance Officers Specifically, there are 88 user types available and almost 60 are available to choose from.
19
PMP Registration Process
Prescription Monitoring Program New Mexico Board of Pharmacy PMP Registration Process Chiropractor Pharmacist Prescriber Delegate – Unlicensed Nurse Practitioner/Clinical Nurse Specialist Out of State Pharmacist Pharmacist in Charge Prescriber Delegate – Licensed Midwife with Prescriptive Authority Psychologist Medical Resident Dispensing Physician Physician Assistant Medical Resident with Prescriptive Authority Dentist Optometrist Out of State Prescriber Naturopathic Physician IHS Prescriber Physician (MD, DO) Pharmacist with Prescriptive Authority Pharmacist’s Delegate – Licensed VA Prescriber Healthcare Provider User Roles
20
PMP Registration Process
Prescription Monitoring Program New Mexico Board of Pharmacy PMP Registration Process Create an account at Verify your by clicking on the link in the auto-generated you received when you created an account. The link is only good for 20 minutes. Contact us to resend if it expires. Upload or a copy of your driver's license, state issued photo ID, or a passport. No other forms of identification will be accepted (for example work badges, Social Security Cards). Complete the required training at
21
PMP Registration Process
Prescription Monitoring Program New Mexico Board of Pharmacy PMP Registration Process Only authorized account holder can access the NM PMP. Sharing login information is a violation of both federal and state regulations.
22
NM BOP PMP Regulatory Facts
Prescription Monitoring Program New Mexico Board of Pharmacy NM BOP PMP Regulatory Facts Dispensers All dispensers (including dispensing practitioners) must report within one business day if more than 12 doses within a 72 hour period was dispensed. If you do routinely dispense, but do not do so during a specific reporting period, a “zero report” must be submitted weekly.
23
NM BOP PMP Regulatory Facts
Prescription Monitoring Program New Mexico Board of Pharmacy NM BOP PMP Regulatory Facts Practitioner Before a practitioner prescribes or dispenses an opioid for the first time to a patient, the practitioner shall obtain and review a report from the PMP for the previous 12 months, and obtain and review the PMP report from an adjacent state if available. A practitioner shall obtain and review a report from the state’s PMP and adjacent states, no less than once every three months for each established patient for whom opioids are prescribed or dispensed.
24
NM BOP PMP Regulatory Facts
Prescription Monitoring Program New Mexico Board of Pharmacy NM BOP PMP Regulatory Facts Exceptions for Practitioners A practitioner does not have to consult the PMP report before prescribing, ordering, or dispensing a controlled substance II-V: If the dispensed quantity is for a period of 4 days or less, To a patient in a nursing facility, To a patient in hospice care, Or when prescribing, dispensing or administering testosterone, pregabalin, lacosamine, ezogabine or stimulant therapy for pediatric patients less than age 14.
25
NM BOP PMP Regulatory Facts
Prescription Monitoring Program New Mexico Board of Pharmacy NM BOP PMP Regulatory Facts Pharmacists Review PMP reports covering at least one year and another states’ report if applicable and available. PMP reports shall be reviewed a minimum of once every three months during the continuous use of opioids.
26
NM BOP PMP Regulatory Facts
Prescription Monitoring Program New Mexico Board of Pharmacy NM BOP PMP Regulatory Facts Exception for Pharmacists A prescription for an opioid written for a patient in a long term care facility (LTCF) or for a patient with a medical diagnosis documenting a terminal illness is exempt from Subsection E of NMAC. If there is any question whether a patient may be classified as having a terminal illness, the pharmacist shall contact the practitioner. The pharmacist shall document whether the patient is “terminally ill” or an “LTCF patient”.
27
NM BOP PMP Regulatory Facts
Prescription Monitoring Program New Mexico Board of Pharmacy NM BOP PMP Regulatory Facts DENTISTRY (DENTISTS, DENTAL HYGIENISTS, ETC.) NMAC - MANAGEMENT OF PAIN WITH CONTROLLED SUBSTANCES MEDICINE AND SURGERY PRACTITIONERS NMAC MANAGEMENT OF PAIN WITH CONTROLLED SUBSTANCES MIDWIVES NMAC - CERTIFIED NURSE MIDWIVES NURSING AND HEALTH CARE RELATED PROVIDERS NMAC - MANAGEMENT OF CHRONIC PAIN WITH CONTROLLED SUBSTANCES
28
NM BOP PMP Regulatory Facts
Prescription Monitoring Program New Mexico Board of Pharmacy NM BOP PMP Regulatory Facts OPTOMETRIC PRACTITIONERS NMAC - MANAGEMENT OF PAIN WITH CONTROLLED SUBSTANCES OSTEOPATHIC MEDICINE AND SURGERY PRACTITIONERS NMAC - PRESCRIBING AND DISTRIBUTION OF CONTROLLED SUBSTANCES PHARMACISTS NMAC - PHARMACIST NMAC - CONTROLLED SUBSTANCES NMAC - CONTROLLED SUBSTANCE PRESCRIPTION MONITORING PROGRAM PODIATRISTS NMAC - MANAGEMENT OF PAIN WITH CONTROLLED SUBSTANCES
29
Prescription Monitoring Program
New Mexico Board of Pharmacy PMP InterConnect The PMP InterConnect (PMPi) facilitates the transfer of PMP data across state lines. PMPi allows participating states across the United States to be linked, providing a more effective means of combating drug diversion and drug abuse nationwide. Currently, 45 states and jurisdictions have agreed to securely share PMP data through PMPi. There were 15 million interstate transactions a month in 2017. Source:
30
PMP InterConnect Prescription Monitoring Program
New Mexico Board of Pharmacy PMP InterConnect Source:
31
PMP AWARxE https://newmexico.pmpaware.net/login
Prescription Monitoring Program New Mexico Board of Pharmacy PMP AWARxE
32
Prescription Monitoring Program
New Mexico Board of Pharmacy
33
Prescription Monitoring Program
New Mexico Board of Pharmacy Patient Alerts – This feature is when the NM BOP specifically provides a report to practitioners and PICs on patients who meet certain criteria. This is not intended to share information on patients who failed a drug test or they are selling their drugs. If you come across a situation like this, call the dispensing pharmacy, other HCPs, and local PD if appropriate.
34
Prescription Monitoring Program
New Mexico Board of Pharmacy
35
Prescription Monitoring Program
New Mexico Board of Pharmacy Recommend doing “Partial Search” (3 characters each). If multiple patients are found, you’ll have the opportunity to select which report or reports you want to view. If they need to be consolidated, contact the NM BOP. If you are needing to search adjacent states, you’ll need to enter the patient’s full first and last name; no partial spelling. This is why it is important to enter patient information per their state issued ID. Do not enter “M” for Maria’s first name or “Worker’s Comp” because you want a separate profile. This impacts the reporting that is submitted into the PMP and what is returned to a user querying a report.
36
Prescription Monitoring Program
New Mexico Board of Pharmacy NM is connected with 25 other states. NOTE: If you select “Partial Search”, the PMPi Search disappears. Best practice if you need PMPi data – search the patient by their driver’s license.
37
Prescription Monitoring Program
New Mexico Board of Pharmacy Here is an example of a Patient Report from the web. Pay attention to he pharmacies and prescribers. Each individual pharmacy and prescriber is counted as 1, so a chain of pharmacies or a clinic of practitioners are not grouped as one. The PDF and the CSV file will not show the “suspected prescriber/pharmacy shopper alert”.
38
Prescription Monitoring Program
New Mexico Board of Pharmacy
39
Prescription Monitoring Program
New Mexico Board of Pharmacy Supervisors will be able to see if their delegates have more than one supervisor listed here.
40
Prescription Monitoring Program
New Mexico Board of Pharmacy Supervisors will be able to see if their delegates have more than one supervisor listed here.
41
Prescription Monitoring Program
New Mexico Board of Pharmacy
42
Prescription Monitoring Program
New Mexico Board of Pharmacy MyRx MyRx gives users that have a DEA number associated with their account to run a self-report to see what prescriptions have been filled where they were listed as the prescriber. Proactive measure for prescribers to help curb forgeries and diversion. Source:
43
Prescription Monitoring Program
New Mexico Board of Pharmacy
44
Reports Available Quarterly Reports to Licensing Boards
Prescription Monitoring Program New Mexico Board of Pharmacy Reports Available Quarterly Reports to Licensing Boards Prescriber Feedback Report
45
Quarterly Reports to Licensing Boards
Prescription Monitoring Program New Mexico Board of Pharmacy Quarterly Reports to Licensing Boards Total number of patients Total number of opioid patients Total opioid Morphine Milligram Equivalents (MME) filled Total number of benzodiazepine (BZD) patients Total BZD Diazepam Milligram Equivalents (DME) filled Percent of opioid patients with ≥90 MME/day Percent of opioid patients with ≥90 days of opioids in 6 months Percent of BZD patients with prescriptions ≥30 DME/day Percent of BZD patients with ≥90 days of BZDs in 6 months Percent of opioid patients with concurrent BZDs ≥30 days
46
Quarterly Reports to Licensing Boards
Prescription Monitoring Program New Mexico Board of Pharmacy Quarterly Reports to Licensing Boards Controlled substance prescriptions per prescribing day, 3 months Percent of estimated required reports requested PMP reports required under Board rules (estimated) PMP reports requested on patients Percent of patients with a total of 5 or more practitioners or pharmacies in 6 months
47
Prescriber Feedback Report
Prescription Monitoring Program New Mexico Board of Pharmacy Prescriber Feedback Report Reports reflect top 1% of prescribers with 20 or more patients receiving controlled substances within 6 month period High opioid doses Long term opioid patients High benzodiazepine (BZD) doses Long term BZD patients High volume of opioids and BZDs High volume prescribing Concurrent therapy Multiple provider episodes No PMP use High opioid doses: Percent of opioid patients prescribed opioid doses >=90 morphine milligram equivalents (MME) per day. Long term: Percent of opioid patients with >=90 days of coverage in six months. High benzodiazepines doses: Percent of benzodiazepine patients prescribed doses >=30 diazepam milligram equivalents (DME) per day Long term: Percent of benzodiazepine patients with >=90 days of coverage in six months. High volume of opioids and benzos: the total MME/DME filled by patients High volume prescribing: the number of controlled substance prescriptions written per prescribing day in the most recent quarter. Concurrent therapy: Percent of patients receiving opioids and benzodiazepines for 30 days or more Multiple provider episodes: Percent of patients using a combination of 5 or more prescribers or pharmacies. No PMP use
48
Prescription Monitoring Program
New Mexico Board of Pharmacy Yellow shading represents top 10% of referenced specialty. Survey link is provided to those who receive this report. If yellow shading does not seem appropriate, double check your specialty designation on the National Provider Index (NPI).
49
Current Projects PMP Integration within Workflow EDIE NarxCare
Prescription Monitoring Program New Mexico Board of Pharmacy Current Projects PMP Integration within Workflow EDIE NarxCare The Narx Report includes a patient’s NarxScores, Predictive Risk Scores, Red Flags, Rx Graph and PDMP Data, as well as access to Resources and Care Team Communications all in a single, easy-to-use interface.
50
Prescription Monitoring Program
New Mexico Board of Pharmacy Useful Links NM Board of Pharmacy PMP Registration and FAQs PMP AWARxE Support Technical Customer Service (24/7/365) Local Non-Technical (M-F 8a-5p) NM BOP PMP Support
51
Questions? Prescription Monitoring Program
New Mexico Board of Pharmacy Questions?
Similar presentations
